Company Information
- Type:
- Company
- Country:
- Japan
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 18 January 2022 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 2023 deadline to be announced (not before October 2023)